Bronchiolitis in a rheumatoid arthritis patient receiving auranofin.
A patient with severe rheumatoid arthritis and sicca symptoms was treated with auranofin. During auranofin therapy, she developed irreversible airways obstruction due to bronchiolitis. Whereas this complication could have been due to her underlying disease, we discuss here the possibility of its being related to the auranofin therapy.
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001310:Auranofin; D006051:Aurothioglucose / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001991:Bronchitis / Q000139:chemically induced*; D005260:Female; D006046:Gold / Q000031:analogs & derivatives*; D006801:Humans
D006051:Aurothioglucose; D001310:Auranofin; D006046:Gold